Budget Impact Analysis of Smart Infusion Pumps With Dedicated Equipment vs. Pumps With Basic Programming in Infusion Therapy in ICU
Author(s)
CRISTINA NUNES FERREIRA, Sr., MBA, MSc, PharmD1, Lucas Scultori, Pharmacy Student1, Miguel F B de Medeiros, MBA2.
1B. Braun Brazil, Rio de Janeiro, Brazil, 2Market Access, B. Braun Brazil, São Paulo, Brazil.
1B. Braun Brazil, Rio de Janeiro, Brazil, 2Market Access, B. Braun Brazil, São Paulo, Brazil.
Presentation Documents
OBJECTIVES: To analyze the hospitalization costs of using smart infusion pumps and dedicated equipment versus pumps with basic programming in ICU infusion therapy.
METHODS: Budget impact analysis (1-year horizon) from the payer's perspective. A scenario of 20 high-complexity ICU beds and the following pharmacoeconomic data were considered: 28 days of hospitalization (14 of them in ICU), cost of R$1,180.00 per day, overall mortality rate of 0.6%, cost of R$24,000.00 per death and R$16,520.00 per failures in infusion therapy, useful life of 48 hours for pump equipment with basic programming and 96 hours for smart pumps, at respective unit costs of R$840.00 and R$1,110.00; 26% vs 15% of failures in infusion therapy by pump with basic programming and smart pumps, respectively.
RESULTS: Despite the higher unit cost, smart pump equipment represents savings in the 15-day scenario, due to greater durability (R$ 4,440.00 vs R$ 5,880.00). When accounting for annual costs with materials and medical assistance due to failures, smart pumps with dedicated equipment present savings of 35% (R$ 192,240.00 vs R$ 296,896.00).
CONCLUSIONS: Smart pumps with dedicated equipment present savings of 35% per year, considering the time the equipment remains in place, reduction in the possibility of failures in infusion therapy, shorter patient hospitalization time and probability of death, which places this technology with the potential to promote high-valued care, by providing better outcomes at lower costs.
METHODS: Budget impact analysis (1-year horizon) from the payer's perspective. A scenario of 20 high-complexity ICU beds and the following pharmacoeconomic data were considered: 28 days of hospitalization (14 of them in ICU), cost of R$1,180.00 per day, overall mortality rate of 0.6%, cost of R$24,000.00 per death and R$16,520.00 per failures in infusion therapy, useful life of 48 hours for pump equipment with basic programming and 96 hours for smart pumps, at respective unit costs of R$840.00 and R$1,110.00; 26% vs 15% of failures in infusion therapy by pump with basic programming and smart pumps, respectively.
RESULTS: Despite the higher unit cost, smart pump equipment represents savings in the 15-day scenario, due to greater durability (R$ 4,440.00 vs R$ 5,880.00). When accounting for annual costs with materials and medical assistance due to failures, smart pumps with dedicated equipment present savings of 35% (R$ 192,240.00 vs R$ 296,896.00).
CONCLUSIONS: Smart pumps with dedicated equipment present savings of 35% per year, considering the time the equipment remains in place, reduction in the possibility of failures in infusion therapy, shorter patient hospitalization time and probability of death, which places this technology with the potential to promote high-valued care, by providing better outcomes at lower costs.
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
EE178
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
No Additional Disease & Conditions/Specialized Treatment Areas